ovarian cancer

Zydus gets COFEPRIS nod to market  Bhava to treat various cancers

Read more

NATCO announces ANDA filing for generic olaparib tablets in US

Read more

BDR Pharma launches generic Rucaparib to treat advanced ovarian and prostate cancers

Read more

LYNPARZA (olaparib) get three new approvals in Japan

Read more

Zydus Cadila gets US FDA approval for Doxorubicin Hydrochloride Liposome Injection

Read more

AstraZeneca-Merck’s Lynparza wins approval in China for ovarian cancer treatment,

Read more